Evidence map›Paper›PMID 30276663›Full record

ArticleMolecular neurobiology2019

Evidence Supporting a Role for the Blood-Cerebrospinal Fluid Barrier Transporting Circulating Ghrelin into the Brain.

Maia Uriarte, Pablo Nicolás De Francesco, Gimena Fernandez, Agustina Cabral, Daniel Castrogiovanni, Tyler Lalonde, Leonard G Luyt, Sebastian Trejo, Mario Perello

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 70 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Low Levels of Serum Ghrelin and Nesfatin-1 Are Associated With Anxiety Disorders in Children.Journal of the Korean Academy of Child and Adolescent Psychiatry · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Maia UriarteLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Pablo Nicolás De FrancescoLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Gimena FernandezLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Agustina CabralLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Daniel CastrogiovanniLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Tyler LalondeDepartment of Oncology, London Regional Cancer Program, 790 Commissioners Rd. E., London, ON, N6A 4L6, Canada.
Leonard G LuytDepartment of Oncology, London Regional Cancer Program, 790 Commissioners Rd. E., London, ON, N6A 4L6, Canada.
Sebastian TrejoLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina.
Mario PerelloLaboratory of Neurophysiology of the Multidisciplinary Institute of Cell Biology [Argentine Research Council (CONICET), Scientific Research Commission of the Province of Buenos Aires (CIC-PBA) and National University of La Plata (UNLP)], Calle 526 S/N entre 10 y 11-PO Box 403, 1900, La Plata, Buenos Aires, Argentina. marioperello@yahoo.com.ORCID http://orcid.org/0000-0003-2114-6765
Consejo Nacional de Investigaciones Científicas y Técnicas · ARWestern University · CA

Funding

NCI CLINICAL INVESTIGATOR AWARDK08CA001084 · NCI · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI GRAHAM, WILLIAM R · 1985 to 1985
–
Agencia Nacional de Promoción Científica y Tecnológica PICT2016-1084Canadian Institutes of Health Research no award numberNatural Sciences and Engineering Research Council of Canada no award number
6 · The paper itself

Abstract

The stomach-derived hormone ghrelin mainly acts in the brain. Studies in mice have shown that the accessibility of ghrelin into the brain is limited and that it mainly takes place in some circumventricular organs, such as the median eminence. Notably, some known brain targets of ghrelin are distantly located from the circumventricular organs. Thus, we hypothesized that ghrelin could also access the brain via the blood-cerebrospinal fluid (CSF) barrier, which consists of the choroid plexus and the hypothalamic tanycytes. Using systemic injection of ghrelin or fluorescent-ghrelin in mice, we found that cells of the blood-CSF barrier internalize these molecules. In time-response studies, we found that peripherally injected fluorescent-ghrelin quickly reaches hypothalamic regions located in apposition to the median eminence and more slowly reaches the periventricular hypothalamic parenchyma, adjacent to the dorsal part of the third ventricle. Additionally, we found that CSF ghrelin levels increase after the systemic administration of ghrelin, and that central infusions of either an anti-ghrelin antibody, which immuno-neutralizes CSF ghrelin, or a scrambled version of ghrelin, which is also internalized by cells of the blood-CSF barrier, partially impair the orexigenic effect of peripherally injected ghrelin. Thus, current evidence suggests that the blood-CSF barrier can transport circulating ghrelin into the brain, and that the access of ghrelin into the CSF is required for its full orexigenic effect.

Indexed as

AnimalsAntibodiesBlood-Brain BarrierCerebral VentriclesCerebrospinal FluidGhrelinMaleMice, Inbred C57BLOrexinsAntibodiesGhrelinOrexinsChoroid plexusEpendymal cellsGhrelinHypothalamusTanycytes

Identifiers

PMID30276663
OpenAlexW2895636463

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.